Send us Feedback

Advanced Medical Optics (EYE)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
OPERATING METRICS
REVENUE SOURCES
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EYE » Topics » Share-Based Compensation Expense

This excerpt taken from the EYE 10-Q filed Nov 5, 2008.

Share-Based Compensation Expense

Total share-based compensation expense included in the unaudited consolidated statements of operations for the three and nine months ended September 26, 2008 and September 28, 2007 was as follows (in thousands):

 

     Three Months Ended     Nine Months Ended  
   September 26, 2008     September 28, 2007     September 26, 2008     September 28, 2007  

Cost of sales

    $ 571     $ 607     $ 1,496     $ 1,771  
                                

Operating Expenses—

         

Research and development

      732       849       2,309       2,148  

Selling, general and administrative

      4,632       4,209       13,419       11,585  

Restructuring charges

      287       —         1,090       —    
                                
     5,651       5,058       16,818       13,733  
                                

Pre-tax expense

      6,222       5,665       18,314       15,504  

Income tax benefit

      (2,105 )     (1,878 )     (6,103 )     (4,960 )
                                

After tax expense

    $ 4,117     $ 3,787     $ 12,211     $ 10,544  
                                

Approximately $0.3 million and $1.1 million of pre-tax share-based compensation expense was included in restructuring charges in the unaudited consolidated statements of operations for the three and nine months ended September 26, 2008, respectively, due to acceleration of vesting of certain awards in connection with the restructuring.

This excerpt taken from the EYE 10-Q filed Aug 6, 2008.

Share-Based Compensation Expense

Total share-based compensation expense included in the unaudited consolidated statements of operations for the three and six months ended June 27, 2008 and June 29, 2007 was as follows (in thousands):

 

     Three Months Ended     Six Months Ended  
     June 27, 2008     June 29, 2007     June 27, 2008     June 29, 2007  

Cost of sales

    $ 467     $ 583     $ 925     $ 1,164  
                                

Operating Expenses—

         

Research and development

      849       709       1,577       1,299  

Selling, general and administrative

      4,867       3,801       8,787       7,376  

Restructuring charges

      687       —         803       —    
                                
     6,403       4,510       11,167       8,675  
                                

Pre-tax expense

      6,870       5,093       12,092       9,839  

Income tax benefit

      (2,251 )     (1,608 )     (3,998 )     (3,083 )
                                

After tax expense

    $ 4,619     $ 3,485     $ 8,094     $ 6,756  
                                

 

15

Table of Contents

Approximately $0.7 million and $0.8 million of pre-tax share-based compensation expense was included in restructuring charges in the unaudited consolidated statements of operations for the three and six months ended June 27, 2008 due to acceleration of vesting, respectively.

This excerpt taken from the EYE 10-Q filed May 7, 2008.

Share-Based Compensation Expense

Total share-based compensation expense included in the unaudited consolidated statements of operations for the three months ended March 28, 2008 and March 30, 2007 was as follows (in thousands):

 

     Three Months Ended
March 28, 2008		     Three Months Ended
March 30, 2007		  

Cost of sales

    $ 458     $ 581  
                

Operating Expenses -

     

Research and development

      728       590  

Selling, general and administrative

      3,920       3,575  

Restructuring charges

      116       —    
                
     4,764       4,165  
                

Pre-tax expense

      5,222       4,746  

Income tax benefit

      (1,747 )     (1,474 )
                

Share-based compensation expense, net of tax

    $ 3,475     $ 3,272  
                

Approximately $0.1 million of pre-tax share-based compensation expense was included in restructuring charges in the unaudited consolidated statements of operations for the three months ended March 28, 2008 due to acceleration of vesting.

This excerpt taken from the EYE 10-Q filed Nov 8, 2007.

Share-Based Compensation Expense

Total share-based compensation expense included in the unaudited consolidated statements of operations for the three and nine months ended September 28, 2007 and September 29, 2006 was as follows (in thousands):

 

     Three Months Ended     Nine Months Ended  
     September 28,
2007		     September 29,
2006		     September 28,
2007		     September 29,
2006		  

Cost of sales

    $ 607     $ 552     $ 1,771     $ 1,709  
                                

Operating Expenses—Research and development

      849       542       2,148       1,599  

Selling, general and administrative

      4,209       3,426       11,585       11,474  
                                
     5,058       3,968       13,733       13,073  
                                

Pre-tax expense

      5,665       4,520       15,504       14,782  

Income tax benefit

      (1,878 )     (1,479 )     (4,960 )     (4,866 )
                                

After tax expense

    $ 3,787     $ 3,041     $ 10,544     $ 9,916  
                                
This excerpt taken from the EYE 10-Q filed Nov 7, 2007.

Share-Based Compensation Expense

Total share-based compensation expense included in the unaudited consolidated statements of operations for the three and nine months ended September 28, 2007 and September 29, 2006 was as follows (in thousands):

 

     Three Months Ended     Nine Months Ended  
     September 28,
2007		     September 29,
2006		     September 28,
2007		     September 29,
2006		  

Cost of sales

    $ 607     $ 552     $ 1,771     $ 1,709  
                                

Operating Expenses—Research and development

      849       542       2,148       1,599  

Selling, general and administrative

      4,209       3,426       11,585       11,474  
                                
     5,058       3,968       13,733       13,073  
                                

Pre-tax expense

      5,665       4,520       15,504       14,782  

Income tax benefit

      (1,878 )     (1,479 )     (4,960 )     (4,866 )
                                

After tax expense

    $ 3,787     $ 3,041     $ 10,544     $ 9,916  
                                
This excerpt taken from the EYE 10-Q filed Aug 8, 2007.

Share-Based Compensation Expense

Total share-based compensation expense included in the unaudited consolidated statements of operations for the three and six months ended June 29, 2007 and June 30, 2006 was as follows (in thousands):

 

     Three Months Ended     Six Months Ended  
     June 29,
2007		     June 30,
2006		     June 29,
2007		     June 30,
2006		  

Cost of sales

    $ 583     $ 617     $ 1,164     $ 1,157  
                                

Operating Expenses—

         

Research and development

      709       577       1,299       1,057  

Selling, general and administrative

      3,801       3,997       7,376       8,048  
                                
     4,510       4,574       8,675       9,105  
                                

Pre-tax expense

      5,093       5,191       9,839       10,262  

Income tax benefit

      (1,608 )     (1,704 )     (3,083 )     (3,387 )
                                

After tax expense

    $ 3,485     $ 3,487     $ 6,756     $ 6,875  
                                
This excerpt taken from the EYE 10-Q filed May 9, 2007.

Share-Based Compensation Expense

Total share-based compensation expense included in the unaudited consolidated statements of operations for the three months ended March 30, 2007 and March 31, 2006 was as follows (in thousands):

 

6

     Three Months Ended
March 30, 2007		     Three Months Ended
March 31, 2006		  

Cost of sales

    $ 581     $ 540  
                

Operating Expenses -

     

Research and development

      590       480  

Selling, general and administrative

      3,575       4,051  
                
     4,165       4,531  
                

Pre-tax expense

      4,746       5,071  

Income tax benefit

      (1,474 )     (1,683 )
                

Net of tax expense

    $ 3,272     $ 3,388  
                

EXCERPTS ON THIS PAGE:

10-Q
Nov 5, 2008
10-Q
Aug 6, 2008
10-Q
May 7, 2008
10-Q
Nov 8, 2007
10-Q
Nov 7, 2007
10-Q
Aug 8, 2007
10-Q
May 9, 2007

RELATED TOPICS for EYE:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki